The eyes in diabetes and diabetes through the eyes

Fong, 2004, Retinopathy in diabetes, Diabetes Care, 27, S84, 10.2337/diacare.27.2007.S84 Harris, 1993, Undiagnosed NIDDM: clinical and public health issues, Diabetes Care, 16, 642, 10.2337/diacare.16.4.642 Juutilinen, 2007, Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women, Diabetes Care, 30, 292, 10.2337/dc06-1747 The Diabetes Control and Complications Trial Research Group, 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N. Engl. J. Med., 329, 977, 10.1056/NEJM199309303291401 UK Prospective Diabetes Study group, 1998, Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), Lancet, 352, 837, 10.1016/S0140-6736(98)07019-6 UK Prospective Diabetes Study group, 1998, Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38), BMJ, 317, 703, 10.1136/bmj.317.7160.703 Neubauer, 2007, Laser treatment in diabetic retinopathy, Opthalmologica, 22, 95, 10.1159/000098254 Helbig, 2007, Surgery for diabetic retinopathy, Opthalmologica, 22, 103, 10.1159/000098255 Hall, 2006, Review of the pericyte during angiogenesis and its role in cancer and diabetic retinopathy, Toxicol. Pathol., 134, 763, 10.1080/01926230600936290 Fong, 2004, Diabetic retinopathy, Diabetes Care, 27, 2540, 10.2337/diacare.27.10.2540 Chakrabarti, 2000, Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy, Diabetes Metab. Res. Rev., 16, 393, 10.1002/1520-7560(0000)9999:9999<::AID-DMRR157>3.0.CO;2-G Shams, 2006, Role of vascular endothelial growth factors in ocular angiogenesis, Opthalmol. Clin. North Am., 19, 335 Wilkinson-Berka, 2006, The role of growth hormone, insulin-like growth factor and somatostatin in diabetic retinopathy, Curr. Med. Chem., 13, 3307, 10.2174/092986706778773086 Clermont, 2007, Retinal blood flow in diabetes, Microcirculation, 14, 49, 10.1080/10739680601072164 Klein, 1984, The Wisconsin Epidemiological Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years, Arch. Opthalmol., 102, 520, 10.1001/archopht.1984.01040030398010 Klein, 1984, The Wisconsin Epidemiological Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years, Arch. Opthalmol., 102, 527, 10.1001/archopht.1984.01040030405011 Klemp, 2004, Effect of short-term hyperglycemia on multifocal electroretinogram in diabetic patients without retinopathy, Ivest. Opthalmol. Vis. Sci., 45, 3812, 10.1167/iovs.03-1260 Klemp, 2005, The multifocal ERG in diabetic patients without retinopathy during euglycemic clamping, Invest. Opthalmol. Vis. Sci., 46, 2620, 10.1167/iovs.04-1254 Hara, 1998, Efficacy and safety of fluorescein angiography with orally administered sodium fluorescein, Am. J. Ophthalmol., 126, 560, 10.1016/S0002-9394(98)00112-3 Rivellese, 2000, Optical coherence tomography after laser photocoagulation for clinically significant macular edema, Opthalmic. Surg. Lasers, 31, 192, 10.3928/1542-8877-20000501-06 Clinical Practice Recommendations 2007, 2007, Standards of Medical Care in Diabetes 2007, Diabetes Care, 30, S21 Liebl, 2001, Costs of type 2 diabetes in Germany Results of the CODE-2 stud, Dtsch Med Wochenschr, 126, 585, 10.1055/s-2001-14102 2000, Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy, N. Engl. J. Med., 342, 381, 10.1056/NEJM200002103420603 Stratton, 2000, Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational trial, BMJ, 321, 405, 10.1136/bmj.321.7258.405 1996, The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial, Diabetes, 45, 1289, 10.2337/diab.45.10.1289 1996, Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial, JAMA, 276, 1409, 10.1001/jama.1996.03540170053032 Zhang, 2001, Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control, Diabetes Care, 24, 1275, 10.2337/diacare.24.7.1275 Mandarino, 1994, High glucose downregulates glucose transport activity in retinal capillary pericytes but not endothelial cells, Invest. Opthalmol. Vis. Sci., 35, 964 Funatsu, 1992, Effect of rapid glycemic control on progression of diabetic retinopathy, Jpn. J. Opthalmol., 36, 356 Henricsson, 2002, Progression of retinopathy in insulin-treated type 2 diabetic patients, Diabetes care, 25, 381, 10.2337/diacare.25.2.381 Gaede, 2003, Multifactorial Intervention and cardiovascular disease in patients with type 2 diabetes, N. Engl. J. Med., 348, 383, 10.1056/NEJMoa021778 Klein, 1998, The Wisconsin Epidemiological Study of Diabetic Retinopathy. XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes, Opthalmology, 105, 1801, 10.1016/S0161-6420(98)91020-X Klein, 1995, The Wisconsin Epidemiological Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema, Opthalmopathy, 102, 7, 10.1016/S0161-6420(95)31052-4 Hogeboom van Buggenum, 2002, Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy, Diabetologia, 45, 203, 10.1007/s00125-001-0747-8 Chaturverdi, 1998, Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes: the EUCLID Study Group; EURODIAB controlled trial of lisinopril in insulin-dependent diabetes mellitus, Lancet, 351, 28, 10.1016/S0140-6736(97)06209-0 Sjolie, 2005, The DIbetic Candesartan Trials (DIRECT) program: baseline characteristics, J. Renin Angiotensin Aldosterone Syst., 6, 25, 10.3317/jraas.2005.003 Gupta, 2004, Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema, Am. J. Ophthalmol., 137, 675 Sen, 2002, Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia, Diabetes Res. Clin. Pract., 56, 1, 10.1016/S0168-8227(01)00341-2 Chowdhury, 2002, The role of serum lipids in exudative diabetic maculopathy: is there a place for lipid lowering therapy?, Eye, 16, 689, 10.1038/sj.eye.6700205 Klein, 1991, The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudates, Ophthalmology, 98, 1261, 10.1016/S0161-6420(91)32145-6 Chew, 1996, Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy: the Early Treatment Diabetic Retinopathy Study (ETDRS) report no. 22, Arch. Ophthalmol., 114, 1079, 10.1001/archopht.1996.01100140281004 Chueng, 2007, Obesity and eye diseases, Surv. Opthalmol., 52, 180, 10.1016/j.survophthal.2006.12.003 Stratton, 2001, UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis, Diabetologia, 44, 156, 10.1007/s001250051594 Hirai, 2007, Severe hypoglycemia and smoking in a long-term type 1 diabetic population: Wisconsin Epidemiologic Study of Diabetic Retinopathy, Diabetes Care, 30, 1437, 10.2337/dc06-2264 Davis, 1998, Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic retinopathy Study report #18, Invest. Opthalmol. Vis. Sci., 39, 233 Idris, 2006, Protein kinase C β inhibition: a novel therapeutic strategy for diabetic microangiopathy, Diabetes Vasc. Dis. Res., 3, 172, 10.3132/dvdr.2006.026 The Eyetech Study Group, 2002, Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration, Retina, 22, 143, 10.1097/00006982-200204000-00002 Vinten, 2007, Short-term Effects of intravitreal triamcinalone on retinal vascular leakage and trunk vessel diameters in macular edema, Acta Ophthalmol. Scand., 85, 21, 10.1111/j.1600-0420.2006.00806.x Lang, 2007, Pharmacological treatment of diabetic retinopathy, Opthalmologica, 221, 112, 10.1159/000098256 Soliman, 2006, Resolution of subretinal hemorrhage and fluid after intravitreal bevacizumab in aggressive peripapillary subretinal neovascularization, Acta. Opthalmol. Scand., 84, 707, 10.1111/j.1600-0420.2006.00736.x